• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza in obese travellers: increased risk and complications, decreased vaccine effectiveness

tetano

Editor, Senior Moderator
J Travel Med. 2019 Apr 1. pii: taz020. doi: 10.1093/jtm/taz020. [Epub ahead of print]
[h=1]Influenza in obese travellers: increased risk and complications, decreased vaccine effectiveness.[/h] Honce R[SUP]1,[/SUP][SUP]2[/SUP], Schultz-Cherry S[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Obesity is a worldwide epidemic and was empirically shown to increase the risk of developing severe influenza virus infection. As international travel becomes more common and obesity is now prevalent even in low- and middle-income countries, travellers may have an increased risk of contracting influenza virus especially during peak influenza season.
[h=4]METHODS:[/h] An analysis of the literature, centered on publications from 2014 to 2019, was performed, with an emphasis on human epidemiological data, human studies ex vivo, and studies in mouse models of obesity. Our search efforts focused on influenza disease severity, pathogenesis, evolutionary dynamics, and measures of infection control in the obese and overweight host.RESULTS: Obesity is associated with an increased risk of infection, as well as a greater chance for hospitalization and severe complications. Studies in mouse models of obesity have uncovered that obese hosts suffer increased viral spread, delayed viral clearance, and heightened damage to the respiratory epithelium. Innate and adaptive immune responses are delayed, thus increasing morbidity and mortality. Further, infection control measures, including vaccination and antivirals, prove less effective in obese hosts. Finally, the obese microenvironment allows for increased duration and amount of viral shedding and potentially increases the chance for emergence of virulent minor variants in the viral population. Together, obese hosts are at high risk of influenza infection, as well as severe sequalae following infection.
[h=4]CONCLUSIONS:[/h] Obese travellers should be aware of influenza activity in the regions visited, as well as take protective measures prior to travel. Vaccination is highly recommended for all travellers, but especially highly susceptible obese travellers.
? International Society of Travel Medicine 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.


[h=4]KEYWORDS:[/h] influenza; obesity; traveller

PMID: 30924873 DOI: 10.1093/jtm/taz020
 
Back
Top Bottom